Glenmede Trust’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.34M | Sell |
8,276
-2,275
| -22% | -$329K | 0.01% | 693 |
|
|
2026
Q1 | $1.25M | Sell |
10,551
-76
| -0.7% | -$9.97K | 0.01% | 671 |
|
|
2025
Q4 | $1.26M | Buy |
+10,627
| New | +$1.21M | 0.01% | 664 |
|
|
2025
Q1 | $1.23M | Sell |
9,630
-23
| -0.2% | -$3.31K | 0.01% | 649 |
|
|
2024
Q4 | $1.47M | Buy |
9,653
+309
| +3% | +$52.3K | 0.01% | 609 |
|
|
2024
Q3 | $1.67M | Buy |
9,344
+46
| +0.5% | +$8K | 0.01% | 607 |
|
|
2024
Q2 | $1.52M | Buy |
9,298
+686
| +8% | +$111K | 0.01% | 614 |
|
|
2024
Q1 | $1.51M | Buy |
8,612
+596
| +7% | +$97.8K | 0.01% | 625 |
|
|
2023
Q4 | $1.35M | Sell |
8,016
-1,266
| -14% | -$185K | 0.01% | 629 |
|
|
2023
Q3 | $1.33M | Sell |
9,282
-734
| -7% | -$120K | 0.01% | 599 |
|
|
2023
Q2 | $1.59M | Hold |
10,016
| – | – | 0.01% | 558 |
|
|
2023
Q1 | $1.59M | Sell |
10,016
-295
| -3% | -$45.3K | 0.01% | 559 |
|
|
2022
Q4 | $1.4M | Sell |
10,311
-1,060
| -9% | -$148K | 0.01% | 587 |
|
|
2022
Q3 | $1.31M | Buy |
11,371
+967
| +9% | +$132K | 0.01% | 586 |
|
|
2022
Q2 | $1.26M | Buy |
10,404
+3,279
| +46% | +$412K | 0.01% | 616 |
|
|
2022
Q1 | $1.01M | Buy |
7,125
+2,020
| +40% | +$287K | 0.01% | 711 |
|
|
2021
Q4 | $900K | Buy |
5,105
+70
| +1% | +$11.7K | ﹤0.01% | 772 |
|
|
2021
Q3 | $777K | Sell |
5,035
-40
| -0.8% | -$5.82K | ﹤0.01% | 773 |
|
|
2021
Q2 | $683K | Sell |
5,075
-133
| -3% | -$17.9K | ﹤0.01% | 795 |
|
|
2021
Q1 | $686K | Buy |
5,208
+123
| +2% | +$16.2K | ﹤0.01% | 757 |
|
|
2020
Q4 | $601K | Buy |
5,085
+229
| +5% | +$26.7K | ﹤0.01% | 803 |
|
|
2020
Q3 | $511K | Buy |
4,856
+691
| +17% | +$73K | ﹤0.01% | 779 |
|
|
2020
Q2 | $444K | Buy |
4,165
+2,370
| +132% | +$220K | ﹤0.01% | 799 |
|
|
2020
Q1 | $158K | Hold |
1,795
| – | – | ﹤0.01% | 1272 |
|
|
2019
Q4 | $158K | Buy |
1,795
+275
| +18% | +$23.7K | ﹤0.01% | 1272 |
|
|
2019
Q3 | $124K | Sell |
1,520
-2,815
| -65% | -$229K | ﹤0.01% | 1326 |
|
|
2019
Q2 | $408K | Buy |
4,335
+1,500
| +53% | +$128K | ﹤0.01% | 959 |
|
|
2019
Q1 | $239K | Buy |
2,835
+305
| +12% | +$22.9K | ﹤0.01% | 1114 |
|
|
2018
Q4 | $158K | Sell |
2,530
-780
| -24% | -$50.3K | ﹤0.01% | 1197 |
|
|
2018
Q3 | $225K | Buy |
3,310
+535
| +19% | +$37.5K | ﹤0.01% | 1103 |
|
|
2018
Q2 | $173K | Buy |
+2,775
| New | +$170K | ﹤0.01% | 1101 |
|
Other funds holding NOVT
CCA
CAM
GKIM
Glenmede Trust's NOVT Position: Q2 2026 in Review
Glenmede Trust reduced its Novanta (NOVT) stake by 22% in Q2 2026, selling an estimated $329K and leaving 8,276 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #693.
Glenmede Trust first reported a position in NOVT in Q2 2018 and has held it in 31 quarters since. The position peaked at $1.67M in Q3 2024. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.
- Glenmede Trust held 8,276 shares of Novanta worth $1.34M as of Q2 2026.
- Glenmede Trust sold 2,275 Novanta shares in Q2 2026, an estimated $329K.
- Novanta made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #693 holding.
- Glenmede Trust first reported a position in Novanta in Q2 2018 and has held it in 31 quarters since.
- Glenmede Trust's Novanta position peaked at $1.67M in Q3 2024.
- 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.